Using PET probes developed at
"The low percentage transition of probes to investigations in humans can be attributed in part to the perception that complex regulatory requirements at high cost are associated with filing for an IND. We believe the information we have provided in our article presents a simpler, low cost approach for allowing more academic sites to transition their promising PET probes to the clinic" notes the author, Dr.
According to the study it is critical for academic sites to have a streamlined and cost-effective approach to translate PET imaging probes from preclinical research to clinical investigations and investigate the degree to which preclinical findings for these probes apply to humans.
ABOUT WORLD MOLECULAR IMAGING SOCIETY
The WMIS is dedicated to developing and promoting translational research through multimodal molecular imaging. The education and abstract-driven WMIC annual meeting is held in conjunction with
For more information: www.wmis.org
Keywords for this news article include: FDA Actions, Nanotechnology,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Criminal Investigation Opened Into James Foley's Death
- Is Diversity in the Eye of the Beholder?
- Apple Stock Bounces Back Big Time
- 'Mythbusters' Build Team Gets the Boot
- Investors Betting on ECB Stimulus Measures
- Jennifer Lopez Would Marry Again
- Florida Judge Rules in Favor of GOP Voter Map
- Mo'Ne Davis a Big Winner Despite Loss
- Hackers Get Homeland Security Employee Records
- DHS Warns Retailers About Malware in Cash Registers